Home/Filings/4/0000200406-25-000054
4//SEC Filing

REED JOHN C 4

Accession 0000200406-25-000054

CIK 0000200406other

Filed

Feb 17, 7:00 PM ET

Accepted

Feb 18, 9:11 PM ET

Size

8.6 KB

Accession

0000200406-25-000054

Insider Transaction Report

Form 4
Period: 2025-02-15
REED JOHN C
EVP, Innovative Medicine, R&D
Transactions
  • Exercise/Conversion

    Common Stock

    2025-02-15+1,35015,927 total
  • Tax Payment

    Common Stock

    2025-02-18$156.15/sh385$60,11815,542 total
  • Exercise/Conversion

    Restricted Share Units

    2025-02-151,3502,698 total
    Common Stock (1,350 underlying)
Footnotes (3)
  • [F1]Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting.
  • [F2]Shares withheld for payment of taxes upon vesting of RSUs.
  • [F3]Each RSU represents a contingent right to receive one share of Company Common Stock.

Issuer

JOHNSON & JOHNSON

CIK 0000200406

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001181561

Filing Metadata

Form type
4
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 9:11 PM ET
Size
8.6 KB